Your session is about to expire
← Back to Search
Study Summary
This trial evaluates a device that may permanently reduce acid reflux in GERD patients without interfering with normal food swallowing. It will assess the device's safety profile and if it can be safely removed if needed.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have a known issue with my esophagus, like a stricture or abnormal shape.I understand the trial requirements and can follow the schedule.I am between 22 and 75 years old with an expected lifespan of more than 3 years.My acid reflux symptoms improve significantly with PPI medication.I take daily medication for acid reflux.I do not have a serious illness that could stop me from following the study rules or that limits my life expectancy to under 3 years.My procedure is classified as an emergency.I am fit for surgery and can undergo general anesthesia.My esophagus has weak muscle movements.I have a hiatal hernia larger than 3cm.I have severe esophagitis.I have been diagnosed with Scleroderma or a disorder affecting how my esophagus moves.I have been diagnosed with Barrett's esophagus.I have had surgery for acid reflux, stomach issues, or stomach cancer.My acid reflux test shows pH<4 for more than 4.5% of the time without GERD medication for 10 days.I have varicose veins in my esophagus or stomach.I have had trouble swallowing more than once a week in the last 3 months.I have a psychiatric condition but am stable on medication if it's depression.I have had a procedure to treat acid reflux.I have or might have cancer in my esophagus or stomach.I cannot undergo major abdominal surgery.I have had GERD symptoms without taking PPIs for at least 10 days.I have had symptoms like heartburn or acid reflux for more than 6 months.
- Group 1: Enrolled patients
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is eligibility for this trial open to those above the age of twenty?
"This clinical trial is accepting participants that are between 22 and 74 years old."
What are the eligibility requirements to participate in this research initiative?
"Those with gastroesophageal reflux disease, aged between 22 and 74 years old, are eligible to participate in this research. The study requires a cohort of 15 individuals."
Are applicants being accepted for this trial at present?
"As reported on clinicaltrials.gov, this medical study is actively reaching out to potential recruits. The investigation was initially set up on April 1st 2023 and had its most recent update on the 3rd of the same month."
What is the aggregate number of participants involved in this medical experiment?
"Affirmative, the information found on clinicaltrials.gov confirms that this experiment is presently seeking volunteers. The trial was first posted on April 1st 2023 and has been revised recently as of April 3rd 2023. This study requires 15 individuals at a single location to participate in it."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
What questions have other patients asked about this trial?
How responsive is this trial?
Typically responds via
Most responsive sites:
- Keck Medical Center of University of Southern California: < 24 hours
Average response time
- < 1 Day
Share this study with friends
Copy Link
Messenger